In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Merck's current price near fair value with modest 2.2% upside and high-confidence valuations signals limited immediate upside. Strong profitability and efficiency offset moderate growth and leverage risks, while Monte Carlo shows significant volatility and notable downside scenarios (52.8%). The broad value range reflects uncertainty driven by varying WACC and growth assumptions.